ECSP067105A - D-tartrato de 1-(indol-6-carbonil-d-fenilglicinil)-4-(l-metilpiperidin-4-il)piperazina - Google Patents
D-tartrato de 1-(indol-6-carbonil-d-fenilglicinil)-4-(l-metilpiperidin-4-il)piperazinaInfo
- Publication number
- ECSP067105A ECSP067105A EC2006007105A ECSP067105A ECSP067105A EC SP067105 A ECSP067105 A EC SP067105A EC 2006007105 A EC2006007105 A EC 2006007105A EC SP067105 A ECSP067105 A EC SP067105A EC SP067105 A ECSP067105 A EC SP067105A
- Authority
- EC
- Ecuador
- Prior art keywords
- phenylglycinyl
- indol
- piperazine
- tartrate
- methylipiperidin
- Prior art date
Links
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 title 2
- FEWJPZIEWOKRBE-LWMBPPNESA-N levotartaric acid Chemical compound OC(=O)[C@@H](O)[C@H](O)C(O)=O FEWJPZIEWOKRBE-LWMBPPNESA-N 0.000 title 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 108010074860 Factor Xa Proteins 0.000 abstract 1
- 229940122055 Serine protease inhibitor Drugs 0.000 abstract 1
- 101710102218 Serine protease inhibitor Proteins 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000003001 serine protease inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58359904P | 2004-06-30 | 2004-06-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP067105A true ECSP067105A (es) | 2007-01-26 |
Family
ID=35276192
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2006007105A ECSP067105A (es) | 2004-06-30 | 2006-12-20 | D-tartrato de 1-(indol-6-carbonil-d-fenilglicinil)-4-(l-metilpiperidin-4-il)piperazina |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20070249623A1 (enExample) |
| EP (1) | EP1763521A1 (enExample) |
| JP (1) | JP2008505075A (enExample) |
| CN (1) | CN1984903A (enExample) |
| AR (1) | AR049659A1 (enExample) |
| AU (1) | AU2005267579A1 (enExample) |
| BR (1) | BRPI0512245A (enExample) |
| CA (1) | CA2570634A1 (enExample) |
| EA (1) | EA010307B1 (enExample) |
| EC (1) | ECSP067105A (enExample) |
| IL (1) | IL179903A0 (enExample) |
| MA (1) | MA28842B1 (enExample) |
| MX (1) | MXPA06015112A (enExample) |
| NO (1) | NO20070486L (enExample) |
| PE (1) | PE20060480A1 (enExample) |
| SV (1) | SV2006002156A (enExample) |
| TW (1) | TW200603806A (enExample) |
| WO (1) | WO2006011955A1 (enExample) |
| ZA (1) | ZA200610091B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0616574D0 (en) * | 2006-08-21 | 2006-09-27 | Glaxo Group Ltd | Compounds |
| CN107365304A (zh) * | 2017-08-01 | 2017-11-21 | 齐宜涛 | 一种治疗心血管疾病的化合物及制备方法和应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA51676C2 (uk) * | 1995-11-02 | 2002-12-16 | Пфайзер Інк. | (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція |
| GB9821058D0 (en) * | 1998-09-28 | 1998-11-18 | Univ Cardiff | Chemical compound |
| ATE304998T1 (de) * | 1999-03-15 | 2005-10-15 | Novo Nordisk As | Salz des (2r,3r,4r)-3,4-dihydroxy-2- hydroxmethylpyrrolidins |
| US6855715B1 (en) * | 1999-06-14 | 2005-02-15 | Eli Lilly And Company | Serine protease inhibitors |
| US6448293B1 (en) * | 2000-03-31 | 2002-09-10 | Pfizer Inc. | Diphenyl ether compounds useful in therapy |
| GB0030304D0 (en) * | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
| GB0019228D0 (en) * | 2000-08-04 | 2000-09-27 | Smithkline Beecham Plc | Novel pharmaceutical |
| EE05441B1 (et) * | 2001-05-14 | 2011-08-15 | Pfizer Products Inc. | 5,8,14-triasatetratsklo[10,3,1,0 2,11,04,9]heksadeka-2(11),3,5,7,9-pentaeeni tartraatsoolad |
| TWI257389B (en) * | 2001-06-12 | 2006-07-01 | Lilly Co Eli | Pharmaceutical compound |
-
2005
- 2005-06-13 CA CA002570634A patent/CA2570634A1/en not_active Abandoned
- 2005-06-13 WO PCT/US2005/020490 patent/WO2006011955A1/en not_active Ceased
- 2005-06-13 BR BRPI0512245-7A patent/BRPI0512245A/pt not_active IP Right Cessation
- 2005-06-13 US US11/570,686 patent/US20070249623A1/en not_active Abandoned
- 2005-06-13 MX MXPA06015112A patent/MXPA06015112A/es not_active Application Discontinuation
- 2005-06-13 CN CNA2005800214090A patent/CN1984903A/zh active Pending
- 2005-06-13 EP EP05760368A patent/EP1763521A1/en not_active Withdrawn
- 2005-06-13 AU AU2005267579A patent/AU2005267579A1/en not_active Abandoned
- 2005-06-13 JP JP2007519246A patent/JP2008505075A/ja active Pending
- 2005-06-13 EA EA200700186A patent/EA010307B1/ru not_active IP Right Cessation
- 2005-06-17 TW TW094120115A patent/TW200603806A/zh unknown
- 2005-06-27 PE PE2005000741A patent/PE20060480A1/es not_active Application Discontinuation
- 2005-06-29 AR ARP050102705A patent/AR049659A1/es unknown
- 2005-06-29 SV SV2005002156A patent/SV2006002156A/es not_active Application Discontinuation
-
2006
- 2006-12-01 ZA ZA200610091A patent/ZA200610091B/en unknown
- 2006-12-07 IL IL179903A patent/IL179903A0/en unknown
- 2006-12-20 EC EC2006007105A patent/ECSP067105A/es unknown
-
2007
- 2007-01-25 NO NO20070486A patent/NO20070486L/no not_active Application Discontinuation
- 2007-01-29 MA MA29641A patent/MA28842B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1984903A (zh) | 2007-06-20 |
| MXPA06015112A (es) | 2007-02-08 |
| MA28842B1 (fr) | 2007-09-03 |
| US20070249623A1 (en) | 2007-10-25 |
| SV2006002156A (es) | 2006-02-15 |
| EA200700186A1 (ru) | 2007-06-29 |
| TW200603806A (en) | 2006-02-01 |
| NO20070486L (no) | 2007-01-25 |
| IL179903A0 (en) | 2007-05-15 |
| AR049659A1 (es) | 2006-08-23 |
| JP2008505075A (ja) | 2008-02-21 |
| BRPI0512245A (pt) | 2008-02-19 |
| AU2005267579A1 (en) | 2006-02-02 |
| CA2570634A1 (en) | 2006-02-02 |
| EA010307B1 (ru) | 2008-08-29 |
| EP1763521A1 (en) | 2007-03-21 |
| PE20060480A1 (es) | 2006-07-13 |
| ZA200610091B (en) | 2008-02-27 |
| WO2006011955A1 (en) | 2006-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20090471T1 (hr) | Derivati prolina i njihova upotreba kao inhibitori dipeptidil-peptidaze iv | |
| AR054846A1 (es) | Formas cristalinas de 4-metil-n-[3-(4-metil-imidazol-1-il)-5-trifluorometil-fenil]-3-(4- piridin-3-il-pirimidin-2- ilamino)-benzamida | |
| UA74372C2 (uk) | Інгібітори серинових протеаз, фармацевтична композиція на їх основі | |
| MX2007005408A (es) | Compuestos de aminoquinazolinas. | |
| ATE407998T1 (de) | Reinigungsmittel | |
| DE502004005033D1 (de) | Substituierte 2-aminotetraline zur behandlung von depressionen | |
| ATE275544T1 (de) | Serinprotease-inhibitoren | |
| EP1694647A4 (en) | CATHEPSINCYSTEINPROTEASEHEMMER | |
| ATE445402T1 (de) | Neue verwendung von pde5-hemmern | |
| NO20081292L (no) | Pentasykliske kinaseinhibitorer | |
| MY137876A (en) | Pharmaceutical compound | |
| DK1641787T3 (da) | Substituerede diketopiperaziner og deres anvendelse som oxytocinantagonister | |
| EA200702201A1 (ru) | Рофлумиласт для лечения лёгочной гипертензии | |
| EA200700186A1 (ru) | Фармацевтическое соединение | |
| SI1517899T1 (sl) | Substituirani benzoksazol sulfonamidi sirokega spektra, ki so HIV proteazni inhibitorji | |
| DOP2005000121A (es) | Compuesto farmaceutico | |
| DK1492767T3 (da) | Visse 1-(D-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazinforbindelser som inhibitorer af serinproteasefaktoren XA | |
| NO20043585L (no) | Behandling av reumatoid artritt | |
| JO2699B1 (en) | New Association of a sinus node IF current inhibitor and an Angiotensin-Converting Enzyme inhibitor, and pharmaceutical compositions containing it. | |
| DE50309647D1 (de) | Ng fibrotischer erkrankungen | |
| IL181183A0 (en) | Enzyme inhibitor in leukemia | |
| SI1492767T1 (sl) | Dolocene 1-(d-ciklopropilglicinil)-4-(piperidin-4-il)piperazinske spojine kot inhibitorji faktorja xa serinske proteaze | |
| TNSN05304A1 (en) | Use of tyrosine kinase inhibitor to treat diabetes | |
| AR052522A1 (es) | Combinacion de un inhibidor selectivo de reabsorcion de noradrenalina y un inhibidor de tipo 5 de fosfodiesterasa | |
| ATE326970T1 (de) | Verwendung von 4-(4-methylpiperazin-1-ylmethyl)-n 4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino) phenyl benzamid zur behandlung von seminomen |